therapy with miRNA to improve the prognosis of patients with this pathology. © 2022 The Authors
Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа, a promising direction is NF1
therapy with STAT3 inhibitors and immune checkpoint inhibitors
Talybov, Rustam,
Beylerli, Ozal,
Mochalov, Vadim,
Prokopenko, Alexey,
Ilyasova, Tatiana,
Trofimova, Tatiana,
Sufianov, Albert,
Guang, Yang (2022) is to note the lack of effectiveness of the MR/CT perfusion technique in
complex multiparametric imaging
. The focus of theoretical study is on understanding the self-assembled
complex structure, governed